Skip to main content
Erschienen in: Pediatric Cardiology 4/2007

01.08.2007 | CASE REPORT

Prolonged Supine Hypertension Due to Midodrine Use in an Orthostatic Hypotensive Child

verfasst von: S. Olgar, R. E. Omeroglu

Erschienen in: Pediatric Cardiology | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Midodrine hydrochloride is a potent peripherally-acting α1 agonist that is well absorbed and rapidly metabolized to its active metabolite. It has been used for the treatment of refractory syncope but has the important side effect of supine hypertension. A 10-year-old boy with severe symptomatic orthostatic hypotension was treated with midodrine. After therapy, syncope attacks ceased but he suffered nighttime headaches, nausea, transient rash and itchy/prickly scalp. Midodrine was discontinued when supine hypertension was noticed. However, his supine hypertension continued until day 19 after discontinuation. This case shows that patients receiving midodrine should be observed for supine hypertension for a prolonged period.
Literatur
1.
Zurück zum Zitat McEvoy GK (2004) Midodrine Hydrochloride. American Hospital Formulary Service Drug Information. American Society of Health-System Pharmacists, Bethesda, MD McEvoy GK (2004) Midodrine Hydrochloride. American Hospital Formulary Service Drug Information. American Society of Health-System Pharmacists, Bethesda, MD
2.
Zurück zum Zitat Roberts Pharmaceutical Corporation (1998) ProAmatine (midodrine hydrochloride) tablets prescribing information (dated 1996 Sep). In: Physicians’ Desk Reference 1998. Medical Economics, Montvale, NJ, pp 2408–2410 Roberts Pharmaceutical Corporation (1998) ProAmatine (midodrine hydrochloride) tablets prescribing information (dated 1996 Sep). In: Physicians’ Desk Reference 1998. Medical Economics, Montvale, NJ, pp 2408–2410
3.
Zurück zum Zitat Weippl G (1979) Infectious toxic hypotension—effect and dosage of midodrine [Author’s translation]. Padiatr Padol 14:211–216PubMed Weippl G (1979) Infectious toxic hypotension—effect and dosage of midodrine [Author’s translation]. Padiatr Padol 14:211–216PubMed
4.
Zurück zum Zitat Zachariah PK, Bloedow DC, Moyer TP, et al. (1986) Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther 39:586–591PubMedCrossRef Zachariah PK, Bloedow DC, Moyer TP, et al. (1986) Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther 39:586–591PubMedCrossRef
Metadaten
Titel
Prolonged Supine Hypertension Due to Midodrine Use in an Orthostatic Hypotensive Child
verfasst von
S. Olgar
R. E. Omeroglu
Publikationsdatum
01.08.2007
Erschienen in
Pediatric Cardiology / Ausgabe 4/2007
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-006-0169-y

Weitere Artikel der Ausgabe 4/2007

Pediatric Cardiology 4/2007 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.